In Northern Ireland and Wales, they are free to everyone. People who choose to take medication for their dementia usually start taking them soon after being diagnosed. Their decision to do so should ...
This means her son is also predisposed to Alzheimer’s Disease. During the seven-year trial, Geri received a high dose of the actual drug, not the placebo. And it didn't take long before she felt ...
2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab) in July. This was the third new approval since 2021. Kisunla ...